Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Zinc-α2-glycoprotein 1 promotes EMT in colorectal cancer by filamin A mediated focal adhesion pathway.

Ji M, Li W, He G, Zhu D, Lv S, Tang W, Jian M, Zheng P, Yang L, Qi Z, Mao Y, Ren L, Zhong Y, Tu Y, Wei Y, Xu J.

J Cancer. 2019 Aug 29;10(22):5557-5566. doi: 10.7150/jca.35380. eCollection 2019.

2.

Short-term and long-term outcomes of robotic rectal surgery-from the real word data of 1145 consecutive cases in China.

Chang W, Wei Y, Ren L, Jian M, Chen Y, Chen J, Liu T, Huang W, Peng S, Xu J.

Surg Endosc. 2019 Oct 10. doi: 10.1007/s00464-019-07170-6. [Epub ahead of print]

PMID:
31602514
3.

Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis.

Jian M, Chang W, Ren L, Liu T, Chen Y, Wei Y, Lin Q, Xu J, Qin X.

Cancer Manag Res. 2019 Sep 11;11:8315-8326. doi: 10.2147/CMAR.S210185. eCollection 2019.

4.

The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway.

Lin Q, Ren L, Jian M, Xu P, Li J, Zheng P, Feng Q, Yang L, Ji M, Wei Y, Xu J.

Cell Death Dis. 2019 Sep 18;10(10):693. doi: 10.1038/s41419-019-1922-5.

5.

Patients with RAS wild-type right-sided unresectable liver-confined mCRC also benefit from cetuximab plus chemotherapy in first-line treatment.

Zheng P, Ren L, Feng Q, Zhu D, Chang W, He G, Ji M, Jian M, Lin Q, Yi T, Wei Y, Xu J.

Am J Cancer Res. 2018 Nov 1;8(11):2337-2345. eCollection 2018.

6.

Additional Biomarkers beyond RAS That Impact the Efficacy of Cetuximab plus Chemotherapy in mCRC: A Retrospective Biomarker Analysis.

Zheng P, Liang C, Ren L, Zhu D, Feng Q, Chang W, He G, Ye L, Chen J, Lin Q, Yi T, Ji M, Niu Z, Jian M, Wei Y, Xu J.

J Oncol. 2018 Sep 16;2018:5072987. doi: 10.1155/2018/5072987. eCollection 2018.

7.

Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases.

Zheng P, Ren L, Feng Q, Zhu D, Chang W, He G, Ji M, Jian M, Lin Q, Yi T, Wei Y, Xu J.

Cancer Manag Res. 2018 Aug 27;10:2871-2881. doi: 10.2147/CMAR.S161392. eCollection 2018.

8.

Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7.

Tang W, Ji M, He G, Yang L, Niu Z, Jian M, Wei Y, Ren L, Xu J.

Onco Targets Ther. 2017 Apr 7;10:2045-2056. doi: 10.2147/OTT.S131597. eCollection 2017.

9.

Spin injection and inverse Edelstein effect in the surface states of topological Kondo insulator SmB6.

Song Q, Mi J, Zhao D, Su T, Yuan W, Xing W, Chen Y, Wang T, Wu T, Chen XH, Xie XC, Zhang C, Shi J, Han W.

Nat Commun. 2016 Nov 11;7:13485. doi: 10.1038/ncomms13485.

10.

Design of an HF-Band RFID System with Multiple Readers and Passive Tags for Indoor Mobile Robot Self-Localization.

Mi J, Takahashi Y.

Sensors (Basel). 2016 Jul 29;16(8). pii: E1200. doi: 10.3390/s16081200.

11.

High level of serum AFP is an independent negative prognostic factor in gastric cancer.

Chen Y, Qu H, Jian M, Sun G, He Q.

Int J Biol Markers. 2015 Nov 11;30(4):e387-93. doi: 10.5301/jbm.5000167.

PMID:
26349668
12.

Generalized comfort/placebo means should be used in cancer care.

Mi J, Qiu M, Xia Q, Xu J.

Med Hypotheses. 2008 Aug;71(2):319-20. doi: 10.1016/j.mehy.2008.03.003. Epub 2008 Apr 14. No abstract available.

PMID:
18413282
13.

Differentiation of anti-tumour cytotoxic T lymphocytes from autologous peripheral blood lymphocytes in non-Hodgkin's lymphomas.

Chaperot L, Manches O, Mi JQ, Moine A, Jacob MC, Gressin R, Molens JP, Sotto JJ, Leroux D, Bensa JC, Plumas J.

Br J Haematol. 2002 Nov;119(2):425-31.

PMID:
12406081

Supplemental Content

Loading ...
Support Center